Focus

(FOCS): Johnson Fistel Investigates Proposed Sale of Focus Financial Partners Corp; Is $53.00 a Fair Price?

Retrieved on: 
Wednesday, July 12, 2023
Clayton, Dubilier & Rice, LLP, FOCS, Learning, Wall Street, Acquisition, YOY, SAN, Dubilier, Sale, Pharmaceutical industry, Focus

On February 27, 2023, Focus announced that it had entered a deal with Clayton Dubilier & Rice.

Key Points: 
  • On February 27, 2023, Focus announced that it had entered a deal with Clayton Dubilier & Rice.
  • Under the terms of this agreement, shareholders will receive $53.00 per share in an all-cash offer.
  • Nationally recognized, Johnson Fistel is investigating whether the proposed deal represents adequate consideration, especially given one Wall Street analyst had a $55.00 price target on the stock.
  • Additionally, Focus was once valued at over $67 a share in late 2020 and has had steadily increasing revenue YOY since 2019.

Tickets Now Available for wine2wine Business Forum 2023: Celebrating 10 Years of Empowering the Italian Wine Industry

Retrieved on: 
Friday, July 7, 2023
Wine Spectator, Focus, Wine, Marketing, IWA, Business, The Wine Advocate, NEOMA Business School, Strategy, Publication, Knowledge, Graduate Business Forum, Online shopping, Tutoring

VERONA, Italy, July 7, 2023 /PRNewswire-PRWeb/ -- The wine2wine Business Forum, held annually since 2014, has established itself as a crucial meeting point for wine producers and professionals seeking to cultivate and expand their wine businesses on a global scale. The Focus of this year's edition is "Italian Wine Ambassadors: celebrating the past, understanding the present, facing the future." 

Key Points: 
  • The Focus of this year's edition is "Italian Wine Ambassadors: celebrating the past, understanding the present, facing the future."
  • This international network of wine professionals has played a pivotal role in promoting Italian wine worldwide, and their contributions will be showcased throughout the program of wine2wine Business Forum 2023.
  • Overall, this 10th edition of wine2wine Business Forum will empower participants to tackle the pressing issues facing the wine sector and embrace future opportunities.
  • To purchase tickets and explore more about the wine2wine Business Forum 2023, please visit the official website at https://liveshop.vinitaly.com/en/products/ticket-wine2wine-business-foru....

(FOCS): Johnson Fistel Investigates Proposed Sale of Focus Financial Partners Corp; Is $53.00 a Fair Price?

Retrieved on: 
Sunday, July 2, 2023
Clayton, Dubilier & Rice, LLP, FOCS, Learning, Wall Street, Acquisition, YOY, SAN, Dubilier, Sale, Pharmaceutical industry, Focus

On February 27, 2023, Focus announced that it had entered a deal with Clayton Dubilier & Rice.

Key Points: 
  • On February 27, 2023, Focus announced that it had entered a deal with Clayton Dubilier & Rice.
  • Under the terms of this agreement, shareholders will receive $53.00 per share in an all-cash offer.
  • Nationally recognized, Johnson Fistel is investigating whether the proposed deal represents adequate consideration, especially given one Wall Street analyst had a $55.00 price target on the stock.
  • Additionally, Focus was once valued at over $67 a share in late 2020 and has had steadily increasing revenue YOY since 2019.

(FOCS): Johnson Fistel Investigates Proposed Sale of Focus Financial Partners Corp; Is $53.00 a Fair Price?

Retrieved on: 
Wednesday, June 28, 2023
Clayton, Dubilier & Rice, LLP, FOCS, Learning, Wall Street, Acquisition, YOY, SAN, Dubilier, Sale, Pharmaceutical industry, Focus

On February 27, 2023, Focus announced that it had entered a deal with Clayton Dubilier & Rice.

Key Points: 
  • On February 27, 2023, Focus announced that it had entered a deal with Clayton Dubilier & Rice.
  • Under the terms of this agreement, shareholders will receive $53.00 per share in an all-cash offer.
  • Nationally recognized, Johnson Fistel is investigating whether the proposed deal represents adequate consideration, especially given one Wall Street analyst had a $55.00 price target on the stock.
  • Additionally, Focus was once valued at over $67 a share in late 2020 and has had steadily increasing revenue YOY since 2019.

(FOCS): Johnson Fistel Investigates Proposed Sale of Focus Financial Partners Corp; Is $53.00 a Fair Price?

Retrieved on: 
Tuesday, June 20, 2023
Clayton, Dubilier & Rice, LLP, FOCS, Learning, Wall Street, Acquisition, YOY, SAN, Dubilier, Sale, Pharmaceutical industry, Focus

On February 27, 2023, Focus announced that it had entered a deal with Clayton Dubilier & Rice.

Key Points: 
  • On February 27, 2023, Focus announced that it had entered a deal with Clayton Dubilier & Rice.
  • Under the terms of this agreement, shareholders will receive $53.00 per share in an all-cash offer.
  • Nationally recognized, Johnson Fistel is investigating whether the proposed deal represents adequate consideration, especially given one Wall Street analyst had a $55.00 price target on the stock.
  • Additionally, Focus was once valued at over $67 a share in late 2020 and has had steadily increasing revenue YOY since 2019.

FOCUS FINANCIAL PARTNERS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Focus Financial Partners Inc. - FOCS

Retrieved on: 
Thursday, June 15, 2023
Class Action Lawsuit, Professional Services, Legal, Clayton, Dubilier & Rice, FOCS, Quarterdeck Investment Partners, Inc., Partnership, KSF, Dubilier, Sale, Focus

and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Focus Financial Partners Inc. (NasdaqGS: FOCS) to a partnership of Clayton, Dubilier & Rice, LLC and Stone Point Capital LLC.

Key Points: 
  • and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Focus Financial Partners Inc. (NasdaqGS: FOCS) to a partnership of Clayton, Dubilier & Rice, LLC and Stone Point Capital LLC.
  • Under the terms of the proposed transaction, shareholders of Focus will receive $53 in cash for each share of Focus that they own.
  • KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
  • To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com .

(FOCS): Johnson Fistel Investigates Proposed Sale of Focus Financial Partners Corp; Is $53.00 a Fair Price?

Retrieved on: 
Monday, May 15, 2023
Clayton, Dubilier & Rice, LLP, FOCS, Learning, Wall Street, Acquisition, YOY, SAN, Dubilier, Sale, Pharmaceutical industry, Focus

SAN DIEGO, May 15, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Focus Financial Partners Inc. (NASDAQ: FOCS) (“Focus” or the “Company”) breached their fiduciary duties in connection with the proposed sale of the Company to Clayton, Dubilier & Rice.

Key Points: 
  • SAN DIEGO, May 15, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Focus Financial Partners Inc. (NASDAQ: FOCS) (“Focus” or the “Company”) breached their fiduciary duties in connection with the proposed sale of the Company to Clayton, Dubilier & Rice.
  • On February 27, 2023, Focus announced that it had entered a deal with Clayton Dubilier & Rice.
  • Nationally recognized, Johnson Fistel is investigating whether the proposed deal represents adequate consideration, especially given one Wall Street analyst had a $55.00 price target on the stock.
  • Additionally, Focus was once valued at over $67 a share in late 2020 and has had steadily increasing revenue YOY since 2019.

Blueshift Nutrition Elevates Supplement Game with Delicious Flavors - Now on Amazon

Retrieved on: 
Tuesday, May 9, 2023
Taste, Focus, Nutrition, Overalls, Coronavirus Scientific Advisory Board, Palate, Plant, IPA, Immune system, CFU-GEMM, Coffee, Health, Probiotic, Dietary supplement, Soft drink, Redshift, Amazon, Food

BOSTON, May 9, 2023 /PRNewswire/ -- Now available on Amazon, Blueshift Nutrition's lineup of Superblend supplement drinks applies the principles of mixology to transform the experience of taking supplements from a chore to a delight. The company's proprietary FlavorWeaving approach utilizes the complex flavor notes of botanicals, fruits, berries and other active ingredients as a source of complexity and interest instead of masking them with added sugar, artificial sweeteners, or other junk ingredients.

Key Points: 
  • Blueshift Nutrition's proprietary FlavorWeaving approach harnesses the complex flavors of phytonutrient-rich botanicals to craft supplement drinks as delicious as they are effective.
  • "But when you think about the beverages people love most – coffee, red wine, IPA beer – they aren't loved for being sweet.
  • Blueshift doesn't just care about offering craveable flavors; they've invested years into developing some of the most effective formulations on the market.
  • Blueshift is launching on Amazon with three of their best-selling Superblends: Energy + Focus, Immune Ultra, and Pre + Probiotic Ultra.

(FOCS): Johnson Fistel Investigates Proposed Sale of Focus Financial Partners; Is $53.00 a Fair Price?

Retrieved on: 
Tuesday, April 11, 2023
Clayton, Dubilier & Rice, LLP, FOCS, Learning, Wall Street, Acquisition, YOY, SAN, Dubilier, Sale, Pharmaceutical industry, Focus

On February 27, 2023, Focus announced that it had entered a deal with Clayton Dubilier & Rice.

Key Points: 
  • On February 27, 2023, Focus announced that it had entered a deal with Clayton Dubilier & Rice.
  • Under the terms of this agreement, shareholders will receive $53.00 per share in an all-cash offer.
  • Nationally recognized, Johnson Fistel is investigating whether the proposed deal represents adequate consideration, especially given one Wall Street analyst had a $55.00 price target on the stock.
  • Additionally, Focus was once valued at over $67 a share in late 2020 and has had steadily increasing revenue YOY since 2019.

Center Coast Brookfield MLP & Energy Infrastructure Fund Announces Planned Reorganization

Retrieved on: 
Thursday, March 30, 2023
PSG, Focus, RISKS, URL, Boaz Weinstein, Registration statement, Proxy, Trustee, Person, CEN, Sale, Register, Nature, Reading, Special, Form, ARE, Security (finance), Fund, NYSE, Corporate action, Bank

NEW YORK, March 30, 2023 (GLOBE NEWSWIRE) -- Center Coast Brookfield MLP & Energy Infrastructure Fund (NYSE: CEN) announced today that its Board of Trustees approved a proposal by Brookfield Public Securities Group LLC (“PSG”), the investment adviser of CEN, to reorganize CEN into Center Coast Brookfield Midstream Focus Fund (the “Focus Fund”) (the reorganization of CEN into the Focus Fund is the “Reorganization”).

Key Points: 
  • NEW YORK, March 30, 2023 (GLOBE NEWSWIRE) -- Center Coast Brookfield MLP & Energy Infrastructure Fund (NYSE: CEN) announced today that its Board of Trustees approved a proposal by Brookfield Public Securities Group LLC (“PSG”), the investment adviser of CEN, to reorganize CEN into Center Coast Brookfield Midstream Focus Fund (the “Focus Fund”) (the reorganization of CEN into the Focus Fund is the “Reorganization”).
  • The Focus Fund is an open-end fund that is a series of Brookfield Investment Funds, which is also managed by PSG using a similar investment strategy.
  • The proposal to reorganize CEN into the Focus Fund will require the approval of CEN shareholders.
  • Please see the About Center Coast Brookfield MLP & Energy Infrastructure Fund section below for the URL to CEN’s website.